Compare BC & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BC | RGEN |
|---|---|---|
| Founded | 1845 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Homebuilding | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7B | 6.6B |
| IPO Year | N/A | 1995 |
| Metric | BC | RGEN |
|---|---|---|
| Price | $77.34 | $103.52 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 12 |
| Target Price | $83.55 | ★ $167.67 |
| AVG Volume (30 Days) | 656.8K | ★ 1.2M |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.22% | N/A |
| EPS Growth | N/A | ★ 286.96 |
| EPS | N/A | ★ 0.15 |
| Revenue | N/A | ★ $141,236,000.00 |
| Revenue This Year | $9.81 | $14.30 |
| Revenue Next Year | $5.11 | $14.52 |
| P/E Ratio | ★ N/A | $689.70 |
| Revenue Growth | N/A | ★ 35.10 |
| 52 Week Low | $48.83 | $100.99 |
| 52 Week High | $90.25 | $175.77 |
| Indicator | BC | RGEN |
|---|---|---|
| Relative Strength Index (RSI) | 47.41 | 32.43 |
| Support Level | $74.04 | N/A |
| Resistance Level | $84.25 | $129.77 |
| Average True Range (ATR) | 2.95 | 5.90 |
| MACD | -0.34 | -2.01 |
| Stochastic Oscillator | 36.78 | 7.09 |
Brunswick is a leading manufacturer in the marine recreation industry. The firm has more than 60 brands delivering products across propulsion (outboard, sterndrive, and inboard engines, propulsion-related controls, rigging, and propellers), parts, accessories, and technology, and boats (including well-known brands like Boston Whaler and Sea Ray). It also owns 442 Freedom Boat Club locations as well as Boateka, which facilitates transactions in the used-boat market. Brunswick's focus surrounds building the innovative marine and recreational experiences, technologies, and connections supported by quality and innovation.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.